title: 'True' fasting serum insulin level, insulin resistance syndrome and coronary artery disease.
abstract: BACKGROUND
  Increased fasting serum insulin level not associated with hypoglycemia is considered to be a practical indicator of the insulin resistance syndrome, a frequent risk factor for atherosclerosis in industrialized countries. However, in most studies, insulin was measured by using antibodies which cross-react with proinsulin and 31/32, 32/33 split products of insulin. We re-examined the correlations between the insulin resistance syndrome and 'true' fasting serum insulin level.
  
  
  METHODS
  We studied 242 post-menopausal women (age 63 +/- 8 years), a population in whom insulin resistance syndrome is particularly frequent. Serum insulin was measured by a recent specific microparticle immunoassay.
  
  
  RESULTS
  There was a significant correlation between elevated 'true' fasting serum insulin level and various constituents of the insulin resistance syndrome, such as obesity, dyslipidemia (hypertriglyceridemia, increased apolipoprotein B and decreased high-density lipoprotein cholesterol and apolipoprotein A1 concentrations), increased serum glucose, uric acid levels, and plasminogen activator inhibitor type I concentration, as well as increased frequency of diabetes. There was also a correlation between insulin level and various manifestations of coronary artery disease: patients in the highest quartile of 'true' insulin level had significantly more entirely occluded coronary arteries than in the lowest one. Similarly, in the highest insulin quartile more patients had occluded arteries with lumen diameter stenoses greater than 50% (P < 0.05) and more of them had history of previous myocardial infarction approaching the level of significance (P = 0.0587) than in the lowest one. Most of these correlations were also noted in nondiabetic people.
  
  
  CONCLUSIONS
  An increase of 'true' fasting serum insulin level is a useful practical index to identify patients with the insulin resistance syndrome exposed to increased risk of coronary artery disease.
authors.affiliation: Research Center, Montreal Heart Institute, Quebec, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Chaour
authors.forename: P
authors.initials: P
authors.lastname: Théroux
authors.forename: B M
authors.initials: BM
authors.lastname: Gilfix
authors.forename: L
authors.initials: L
authors.lastname: Campeau
authors.forename: J
authors.initials: J
authors.lastname: Lespérance
authors.forename: M
authors.initials: M
authors.lastname: Ghitescu
authors.forename: F
authors.initials: F
authors.lastname: Gélinas
authors.forename: B C
authors.initials: BC
authors.lastname: Solymoss
mesh_terms: D000368:Aged; D016009:Chi-Square Distribution; D003324:Coronary Artery Disease / Q000097:blood*; D005215:Fasting; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D007328:Insulin / Q000097:blood*; D007333:Insulin Resistance; D008055:Lipids / Q000097:blood; D008875:Middle Aged; D017698:Postmenopause; D011863:Radioimmunoassay; D012307:Risk Factors; D018709:Statistics, Nonparametric; D013577:Syndrome
chemical_list: D007328:Insulin; D008055:Lipids